Dr. Gibbs is a T32 CrossROADS scholar mentored by Dr. Girardin Jean-Louis and Dr. Tatjana Rundek. Dr. Carla Gibbs was born in Miami, FL. She received her Ph.D. in Biomedical Sciences with an emphasis in Biochemistry from Meharry Medical College in Nashville, Tennessee, in May 2023. She is trained in a broad scope of science immunology techniques, and contemporary molecular biology research methods. These techniques include DNA genetic engineering, flow cytometry, and pre-clinical research. She completed her graduate training in the Laboratory of Cancer Biology and Genetics (LCBG) at the National Cancer Institute, National Institutes of Health (NCI-NIH) in Bethesda, Maryland. Dr. Gibbs has many years of experience in scientific outreach and as a scientific policy advocate.

Her expertise is in inflammatory and epigenetic pathways, which now include novel pathways in neurodegenerative diseases. Through identifying biomarkers at the intersection of inflammation and sleep disturbances, Dr. Gibbs uses bioinformatic tools and artificial intelligence to develop our understanding of neurodegenerative disease by mining data retrieved from NIH-R01 funded studies, ESSENTIAL and MOSAIC.